○Kouki Shinohara¹, Nobuyo Kuwata², Kohei Tsuji¹, Takahiro Ishii¹, Takuya Kobayakawa¹, Shin-ichiro Hattori², Naoki Kishimoto³, Nobutoki Takamune³, Shogo Misumi³, Bulut Haydar⁴, Hironori Hayashi⁵, Hiroaki Mitsuya^2,4, Hirokazu Tamamura¹ (1. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2. National Center for Global Health and Medicine Research Institute, 3. Faculty of Life Sciences, Kumamoto University, 4. Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 5. International Research Institute of Disaster Science, Tohoku University)

○Soshi Nishimura¹, Takuya Kobayakawa¹, Kohei Tsuji¹, Tsutomu Murakami², Hirokazu Tamamura¹ (1. Inst. Biomater. Bioeng., Tokyo Med. Dent. Univ., 2. National Institute of Infectious Diseases)

○Ayane Kaneko¹, Akira Takagi¹, Kensuke Okuda¹ (1. Kobe Pharm. Univ.)

○Shuji Yoshioka¹, Akari Ikeda^1,2, Yoshihiko Noguchi^1,2, Akari Ueda¹, Yumi Hayashi¹, Rei Hokari², Masato Iwatuki^1,2, Tomoyasu Hirose^1,2, Toshiaki Sunazuka^1,2 (1. Grad. Sch. Infect. Ctl., kitasato Univ., 2. Ōmura Satoshi Memorial Inst., Kitasato Univ.)

○Yifan Huang¹, Marina Sampei², Hiromasa Yokoe^2,3, Fumiaki Ohtake^2,4, Naoki Kanoh^2,3 (1. Graduate School of Pharmaceutical Sciences, Hoshi University, 2. School of Pharmacy and Pharmaceutical Sciences, Hoshi University., 3. Institute of Medicinal Chemistry, Hoshi University, 4. Institute for Advanced Life Sciences, Hoshi University)